柚皮芸香苷结构式
|
常用名 | 柚皮芸香苷 | 英文名 | Narirutin |
---|---|---|---|---|
CAS号 | 14259-46-2 | 分子量 | 580.535 | |
密度 | 1.7±0.1 g/cm3 | 沸点 | 924.3±65.0 °C at 760 mmHg | |
分子式 | C27H32O14 | 熔点 | 152-190ºC | |
MSDS | 中文版 美版 | 闪点 | 307.3±27.8 °C |
柚皮芸香苷用途Narirutin 是从 Citrus unshiu 中分离的活性成分之一,具有抗氧化和抗炎活性。Narirutin 是一种具有抗结核效力的 shikimate 激酶抑制剂。 |
中文名 | 芸香柚皮苷 |
---|---|
英文名 | narirutin |
中文别名 | 柚皮素-7-O-芸香糖苷 | 柚皮芸香苷 |
英文别名 | 更多 |
描述 | Narirutin 是从 Citrus unshiu 中分离的活性成分之一,具有抗氧化和抗炎活性。Narirutin 是一种具有抗结核效力的 shikimate 激酶抑制剂。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.7±0.1 g/cm3 |
---|---|
沸点 | 924.3±65.0 °C at 760 mmHg |
熔点 | 152-190ºC |
分子式 | C27H32O14 |
分子量 | 580.535 |
闪点 | 307.3±27.8 °C |
精确质量 | 580.179199 |
PSA | 225.06000 |
LogP | 2.07 |
外观性状 | 灰白色粉末 |
蒸汽压 | 0.0±0.3 mmHg at 25°C |
折射率 | 1.708 |
储存条件 | 室温 |
安全声明 (欧洲) | 22-24/25 |
---|---|
危险品运输编码 | NONH for all modes of transport |
海关编码 | 29389090 |
Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management.
Evid. Based. Complement. Alternat. Med. 2013 , 479505, (2013) Beneficial health effects of fruits and vegetables in the diet have been attributed to their high flavonoid content. Dipeptidyl peptidase IV (DPP-IV) is a serine aminopeptidase that is a novel target ... |
|
Huanglongbing modifies quality components and flavonoid content of 'Valencia' oranges.
J. Sci. Food Agric. 96 , 73-8, (2016) In order to evaluate the effect of citrus greening disease, or Huanglongbing (HLB), on quality components and flavonoid contents of 'Valencia' oranges, fruit from non-infected trees (control), from in... |
(2S)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl-6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside |
(2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside |
ISONARINGIN |
Isonaringenin |
Naringenin 7-O-rutinoside |
4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (2S)- |
Naringenin-7-rutinoside |
(2S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromen-4-one |
Narirutin |
(2S)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside |
(2S)-5-Hydroxy-2-(4-hydroxyphényl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-méthyltétrahydro-2H-pyran-2-yl]oxy}méthyl)tétrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromén-4-one |
Naringenin 7-rutinoside |
(S)-7-((6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
naringenin-7-O-rutinoside |
Apigenin-7-rutinosid |
(2S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromen-4-on |